Roy Gulick, Weill Cornell Medical College, New York
Although the logic in antiretroviral HIV therapy has, for some years, been that two drugs are better than one; and three are better than two, this has not continued. A late breaking study involving 700 patients presented on this at ICAAC found that four drugs are not better than three, but that a worrying relationship exists between race and time to virologic failure.
Reporting from:
American Heart Association Scientific Sessions, New Orleans, November 7-10, 2004
Scientific Editors:
Michael Petch, Papworth Hospital, Cambridge
Man Fai Shiu, Walsgrave Hospital,
Reporting from:
American Heart Association Scientific Sessions, New Orleans, November 7-10, 2004
In this edition:
In severe heart failure, Teresa De Marco told
JOHN KASTELEIN, Academic Medical Center, Amsterdam
REFERENCE: Abstract 407-7, American College of Cardiolgy New Orleans
A drug which raises HDL and reduces
Post a comment